Cramer Rosenthal Mcglynn LLC boosted its holdings in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 10.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 799,748 shares of the medical instruments supplier’s stock after acquiring an additional 78,668 shares during the quarter. Cramer Rosenthal Mcglynn LLC owned about 0.35% of DENTSPLY SIRONA worth $52,647,000 as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Generation Investment Management LLP grew its holdings in DENTSPLY SIRONA by 115.6% in the fourth quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock valued at $593,238,000 after purchasing an additional 4,831,112 shares during the last quarter. Viking Global Investors LP grew its holdings in DENTSPLY SIRONA by 51.9% in the fourth quarter. Viking Global Investors LP now owns 5,397,707 shares of the medical instruments supplier’s stock valued at $355,331,000 after purchasing an additional 1,844,190 shares during the last quarter. Alyeska Investment Group L.P. grew its holdings in DENTSPLY SIRONA by 223.7% in the third quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock valued at $135,860,000 after purchasing an additional 1,569,746 shares during the last quarter. Frontier Capital Management Co. LLC acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at $60,449,000. Finally, Jackson Square Partners LLC grew its holdings in DENTSPLY SIRONA by 15.6% in the third quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock valued at $378,890,000 after purchasing an additional 855,199 shares during the last quarter. Hedge funds and other institutional investors own 96.80% of the company’s stock.
Shares of DENTSPLY SIRONA Inc (XRAY) opened at $58.42 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.46 and a current ratio of 2.12. The company has a market capitalization of $13,420.00, a price-to-earnings ratio of -8.49, a P/E/G ratio of 2.52 and a beta of 1.20. DENTSPLY SIRONA Inc has a 52 week low of $52.53 and a 52 week high of $68.98.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Wednesday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -5.09%.
In related news, Director Eric Brandt sold 6,409 shares of the stock in a transaction on Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the sale, the director now owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.99% of the stock is owned by company insiders.
Several analysts have weighed in on XRAY shares. Credit Suisse Group lowered DENTSPLY SIRONA to a “hold” rating and set a $73.00 target price on the stock. in a report on Friday, January 5th. HC Wainwright lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 target price on the stock. in a report on Thursday, November 30th. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 8th. JPMorgan Chase & Co. raised DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 target price on the stock in a report on Wednesday, December 13th. Finally, Deutsche Bank started coverage on DENTSPLY SIRONA in a report on Friday, December 8th. They issued a “buy” rating and a $81.00 target price on the stock. Three analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $67.43.
COPYRIGHT VIOLATION WARNING: “DENTSPLY SIRONA Inc (XRAY) Shares Bought by Cramer Rosenthal Mcglynn LLC” was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.americanbankingnews.com/2018/03/13/dentsply-sirona-inc-xray-shares-bought-by-cramer-rosenthal-mcglynn-llc.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.